Sudhir Srivastava

Title: Sudhir Srivastava: Innovator in Pharmaceutical Sciences

Introduction

Sudhir Srivastava is a notable inventor based in Lucknow, India. He has made significant contributions to the field of pharmaceutical sciences, particularly in the treatment of diabetes, dyslipidemia, and malaria. With a total of five patents to his name, his work has the potential to impact public health positively.

Latest Patents

One of his latest patents includes a pharmaceutical composition for the treatment of diabetes and dyslipidemia. This invention features a bioactive fraction that serves as an antidiabetic and antidyslipidemic agent. The fraction can be incorporated into a pharmaceutical composition or utilized in methods for treating these conditions. Another significant patent involves isomeric xyloccensins, which includes the preparation of these compounds and pharmaceutical compositions containing them. These compositions are designed to treat dyslipidemia effectively. Additionally, he has developed a combination kit for the treatment of malaria. This kit includes individual doses of an anti-malarial agent and chloroquine, along with instructional material for administration, tailored for a six-day treatment regimen.

Career Highlights

Throughout his career, Sudhir Srivastava has worked with esteemed organizations such as the Council of Scientific & Industrial Research and Nicholas Piramal India Limited. His experience in these institutions has allowed him to refine his expertise in pharmaceutical research and development.

Collaborations

Sudhir has collaborated with notable coworkers, including Satyawan Singh and Anil Kumar Dwivedi. Their collective efforts have contributed to advancements in pharmaceutical innovations.

Conclusion

Sudhir Srivastava's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His patents reflect a commitment to addressing critical health issues, showcasing the importance of research and collaboration in developing effective treatments.